Me has faced an uncertain future after struggles to find a profitable business model and privacy concerns related to ...

Regeneron Pharmaceuticals announced it won the bankruptcy auction for key assets of 23andMe, according to Benzinga. The $256 ...

Clothing company Levi Strauss announced Tuesday it will sell its Dockers line to Authentic Brands Group in a more than $300 ...

Investors burned by President Trump’s trade fight now have to contend with a spending megabill that risks swelling the ...

The new owner, Regeneron Pharmaceuticals intends to continue providing 23andMe’s consumer genome services, it said.

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.

Pharmaceutical giant Regeneron has promised to prioritise the “ethical use” of the sequenced DNA data of more than 15 million ...

South San Francisco, California-based 23andMe filed for bankruptcy last month, seeking to sell its business at auction after ...

Wall Street indices closed mixed on Monday. Moody's downgraded the U.S. credit rating due to rising debt. S&P 500 marked its ...

The pharmaceutical giant plans to continue offering 23andMe’s DNA testing service and pledged to adopt its privacy practices ...

U.S. District Judge Beryl Howell ruled Monday that a DOGE-lead takeover of the U.S. Institute of Peace was "unlawful" and ...

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies insisted the sensitive genetic data provided to 23andMe by 15 million ...